Outpatient adverse drug events identified by screening electronic health records

Tejal K. Gandhi, Andrew C. Seger, J. Marc Overhage, Michael Murray, Carol Hope, Julie Fiskio, Evgenia Teal, David W. Bates

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

OBJECTIVES:: Relatively little is known about rates of outpatient adverse drug events (ADEs), and most health systems do not routinely identify them. We developed a computerized ADE measurement process and used it to detect ADEs from electronic health records and then categorized them according to type, preventability, and severity. METHODS:: The rules used represent combinations of variables including coded medication names, laboratory results, diagnoses, and specific items such as symptoms from free text clinician notes, all obtained from electronic health records. Rules targeted various diagnostic and laboratory abnormalities potentially caused by a broad range of outpatient medications commonly used in primary care. The rules were run on 4 months of data on primary care patients seen in the outpatient setting in 2 large health systems; possible incidents were identified by chart review and validated as ADEs by clinician reviewers, then rated by severity and preventability. RESULTS:: The rates of ADEs were 75 ADEs/1000 person-years and 198/1000 person-years at the 2 sites, respectively. The overall rate was 138 ADEs/1000 person-years across the 2 sites. Eleven percent of ADEs were preventable, with a rate of 15 preventable ADEs/1000 person-years across sites. Approximately one-fourth of ADEs were serious or life threatening at both sites. The highest yield rules for identifying preventable ADEs included rules based on drug classes and symptoms, and drug-laboratory rules. CONCLUSIONS:: Adverse drug events occurred frequently in routine outpatient care, and many were serious and preventable. Computerized monitoring represents an efficacious approach for identifying ambulatory ADEs, although it needs additional refinement. In addition, site-specific variations need further exploration.

Original languageEnglish (US)
Pages (from-to)91-96
Number of pages6
JournalJournal of Patient Safety
Volume6
Issue number2
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Electronic Health Records
Drug-Related Side Effects and Adverse Reactions
Outpatients
Primary Health Care
Clinical Laboratory Techniques
Health
Ambulatory Care
Pharmaceutical Preparations
Names

Keywords

  • Adverse drug event
  • Ambulatory care
  • Computerized adverse drug event monitor
  • Natural language processing
  • Patient safety

ASJC Scopus subject areas

  • Leadership and Management
  • Public Health, Environmental and Occupational Health

Cite this

Gandhi, T. K., Seger, A. C., Overhage, J. M., Murray, M., Hope, C., Fiskio, J., ... Bates, D. W. (2010). Outpatient adverse drug events identified by screening electronic health records. Journal of Patient Safety, 6(2), 91-96. https://doi.org/10.1097/PTS.0b013e3181dcae06

Outpatient adverse drug events identified by screening electronic health records. / Gandhi, Tejal K.; Seger, Andrew C.; Overhage, J. Marc; Murray, Michael; Hope, Carol; Fiskio, Julie; Teal, Evgenia; Bates, David W.

In: Journal of Patient Safety, Vol. 6, No. 2, 06.2010, p. 91-96.

Research output: Contribution to journalArticle

Gandhi, TK, Seger, AC, Overhage, JM, Murray, M, Hope, C, Fiskio, J, Teal, E & Bates, DW 2010, 'Outpatient adverse drug events identified by screening electronic health records', Journal of Patient Safety, vol. 6, no. 2, pp. 91-96. https://doi.org/10.1097/PTS.0b013e3181dcae06
Gandhi, Tejal K. ; Seger, Andrew C. ; Overhage, J. Marc ; Murray, Michael ; Hope, Carol ; Fiskio, Julie ; Teal, Evgenia ; Bates, David W. / Outpatient adverse drug events identified by screening electronic health records. In: Journal of Patient Safety. 2010 ; Vol. 6, No. 2. pp. 91-96.
@article{20aed177813f4e9dbf79455824eb851e,
title = "Outpatient adverse drug events identified by screening electronic health records",
abstract = "OBJECTIVES:: Relatively little is known about rates of outpatient adverse drug events (ADEs), and most health systems do not routinely identify them. We developed a computerized ADE measurement process and used it to detect ADEs from electronic health records and then categorized them according to type, preventability, and severity. METHODS:: The rules used represent combinations of variables including coded medication names, laboratory results, diagnoses, and specific items such as symptoms from free text clinician notes, all obtained from electronic health records. Rules targeted various diagnostic and laboratory abnormalities potentially caused by a broad range of outpatient medications commonly used in primary care. The rules were run on 4 months of data on primary care patients seen in the outpatient setting in 2 large health systems; possible incidents were identified by chart review and validated as ADEs by clinician reviewers, then rated by severity and preventability. RESULTS:: The rates of ADEs were 75 ADEs/1000 person-years and 198/1000 person-years at the 2 sites, respectively. The overall rate was 138 ADEs/1000 person-years across the 2 sites. Eleven percent of ADEs were preventable, with a rate of 15 preventable ADEs/1000 person-years across sites. Approximately one-fourth of ADEs were serious or life threatening at both sites. The highest yield rules for identifying preventable ADEs included rules based on drug classes and symptoms, and drug-laboratory rules. CONCLUSIONS:: Adverse drug events occurred frequently in routine outpatient care, and many were serious and preventable. Computerized monitoring represents an efficacious approach for identifying ambulatory ADEs, although it needs additional refinement. In addition, site-specific variations need further exploration.",
keywords = "Adverse drug event, Ambulatory care, Computerized adverse drug event monitor, Natural language processing, Patient safety",
author = "Gandhi, {Tejal K.} and Seger, {Andrew C.} and Overhage, {J. Marc} and Michael Murray and Carol Hope and Julie Fiskio and Evgenia Teal and Bates, {David W.}",
year = "2010",
month = "6",
doi = "10.1097/PTS.0b013e3181dcae06",
language = "English (US)",
volume = "6",
pages = "91--96",
journal = "Journal of Patient Safety",
issn = "1549-8417",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Outpatient adverse drug events identified by screening electronic health records

AU - Gandhi, Tejal K.

AU - Seger, Andrew C.

AU - Overhage, J. Marc

AU - Murray, Michael

AU - Hope, Carol

AU - Fiskio, Julie

AU - Teal, Evgenia

AU - Bates, David W.

PY - 2010/6

Y1 - 2010/6

N2 - OBJECTIVES:: Relatively little is known about rates of outpatient adverse drug events (ADEs), and most health systems do not routinely identify them. We developed a computerized ADE measurement process and used it to detect ADEs from electronic health records and then categorized them according to type, preventability, and severity. METHODS:: The rules used represent combinations of variables including coded medication names, laboratory results, diagnoses, and specific items such as symptoms from free text clinician notes, all obtained from electronic health records. Rules targeted various diagnostic and laboratory abnormalities potentially caused by a broad range of outpatient medications commonly used in primary care. The rules were run on 4 months of data on primary care patients seen in the outpatient setting in 2 large health systems; possible incidents were identified by chart review and validated as ADEs by clinician reviewers, then rated by severity and preventability. RESULTS:: The rates of ADEs were 75 ADEs/1000 person-years and 198/1000 person-years at the 2 sites, respectively. The overall rate was 138 ADEs/1000 person-years across the 2 sites. Eleven percent of ADEs were preventable, with a rate of 15 preventable ADEs/1000 person-years across sites. Approximately one-fourth of ADEs were serious or life threatening at both sites. The highest yield rules for identifying preventable ADEs included rules based on drug classes and symptoms, and drug-laboratory rules. CONCLUSIONS:: Adverse drug events occurred frequently in routine outpatient care, and many were serious and preventable. Computerized monitoring represents an efficacious approach for identifying ambulatory ADEs, although it needs additional refinement. In addition, site-specific variations need further exploration.

AB - OBJECTIVES:: Relatively little is known about rates of outpatient adverse drug events (ADEs), and most health systems do not routinely identify them. We developed a computerized ADE measurement process and used it to detect ADEs from electronic health records and then categorized them according to type, preventability, and severity. METHODS:: The rules used represent combinations of variables including coded medication names, laboratory results, diagnoses, and specific items such as symptoms from free text clinician notes, all obtained from electronic health records. Rules targeted various diagnostic and laboratory abnormalities potentially caused by a broad range of outpatient medications commonly used in primary care. The rules were run on 4 months of data on primary care patients seen in the outpatient setting in 2 large health systems; possible incidents were identified by chart review and validated as ADEs by clinician reviewers, then rated by severity and preventability. RESULTS:: The rates of ADEs were 75 ADEs/1000 person-years and 198/1000 person-years at the 2 sites, respectively. The overall rate was 138 ADEs/1000 person-years across the 2 sites. Eleven percent of ADEs were preventable, with a rate of 15 preventable ADEs/1000 person-years across sites. Approximately one-fourth of ADEs were serious or life threatening at both sites. The highest yield rules for identifying preventable ADEs included rules based on drug classes and symptoms, and drug-laboratory rules. CONCLUSIONS:: Adverse drug events occurred frequently in routine outpatient care, and many were serious and preventable. Computerized monitoring represents an efficacious approach for identifying ambulatory ADEs, although it needs additional refinement. In addition, site-specific variations need further exploration.

KW - Adverse drug event

KW - Ambulatory care

KW - Computerized adverse drug event monitor

KW - Natural language processing

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=77953175437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953175437&partnerID=8YFLogxK

U2 - 10.1097/PTS.0b013e3181dcae06

DO - 10.1097/PTS.0b013e3181dcae06

M3 - Article

C2 - 22130350

AN - SCOPUS:77953175437

VL - 6

SP - 91

EP - 96

JO - Journal of Patient Safety

JF - Journal of Patient Safety

SN - 1549-8417

IS - 2

ER -